eNauka - pregled

Pregled prema Autor Tomczak, Piotr

Prikaz rezultata 1 do 2 od 2
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021Preliminary analysis of a phase II, multicenter, randomized, active-control study to evaluate the efficacy and safety of eganelisib (IPI 549) in combination with nivolumab compared to nivolumab monotherapy in patients with advanced urothelial carcinoma.Tomczak, Piotr; Popovic, Lazar S  ; Barthelemy, Philippe; Janicic, Aleksander; Fernandez, Elena Sevillano; Borchiellini, Delphine; Aglietta, Massimo; Maroto, Jose; Carnot, Aurelien; O'Connell, Brenda;
Zizlsperger, Nora; Zhang, Halle Huihong; Valderrama, Begona P;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2007Temsirolimus, interferon alfa, or both for advanced renal-cell carcinomaHudes, Gary; Carducci, Michael; Tomczak, Piotr; Dutcher, Janice; Figlin, Robert; Kapoor, Anil; Staroslawska, Elzbieta; Sosman, Jeffrey; McDermott, David; Bodrogi, Istvan;
Kovacevic, Zoran; Lesovoy, Vladimir; Schmidt-Wolf, Ingo GH; Barbarash, Olga; Gokm;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+